Reto Jost is Category Lead for Large Volume Injectors at Ypsomed Delivery Systems. He has been with Ypsomed since 2014 in various roles in product management and business development, working with pharmaceutical companies to develop and bring to market innovative self-injection systems. Since 2018 his main focus has been on new product innovation, with a particular focus on large volume injections. Mr Jost holds an MSc in Mechanical Engineering from ETH Zurich, Switzerland, and a CAS in Business Administration from HES-SO, Fribourg, Switzerland. He has broad experience in medical devices, having worked in the industry since 2006.

Tobias Theiler is currently Head of Science and Evidence at Ypsomed AG, where he leads the integrated functions of Medical Affairs, Human Factors, and Scientific Evidence Generation. In this role, he drives the scientific strategy for Ypsomed’s self-injection systems, bridging clinical needs with user-centric design. Before joining Ypsomed, Tobias built a background across the medical device sector, working in leading systems engineering roles for more than a decade at Biotronik, Abbott Medical, and Ypsomed AG. Tobias holds a doctorate in Medical Sciences (Dr. rer. medic.) from RWTH Aachen University and a Master of Science in Electrical Engineering from Ruhr University Bochum. His academic research focused on active cardiac implants and electrophysiological pathology. He has authored multiple peer-reviewed publications in these fields.

Andreas Schneider is Head of Innovation at Ypsomed Delivery Systems. He leads business development, strategy, and engineering teams to drive new drug delivery device platforms and service offerings such as next generation autoinjectors and pens, smart connected systems and digital solutions. Andreas has published various articles and given presentations in the areas of innovation management and drug delivery. He holds a PhD in Innovation Management from ETH Zurich, Switzerland.